Cargando…
GFAP at 50
Fifty years have passed since the discovery of glial fibrillary acidic protein (GFAP) by Lawrence Eng and colleagues. Now recognized as a member of the intermediate filament family of proteins, it has become a subject for study in fields as diverse as structural biology, cell biology, gene expressio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440737/ https://www.ncbi.nlm.nih.gov/pubmed/32811163 http://dx.doi.org/10.1177/1759091420949680 |
_version_ | 1783573180461350912 |
---|---|
author | Messing, Albee Brenner, Michael |
author_facet | Messing, Albee Brenner, Michael |
author_sort | Messing, Albee |
collection | PubMed |
description | Fifty years have passed since the discovery of glial fibrillary acidic protein (GFAP) by Lawrence Eng and colleagues. Now recognized as a member of the intermediate filament family of proteins, it has become a subject for study in fields as diverse as structural biology, cell biology, gene expression, basic neuroscience, clinical genetics and gene therapy. This review covers each of these areas, presenting an overview of current understanding and controversies regarding GFAP with the goal of stimulating continued study of this fascinating protein. |
format | Online Article Text |
id | pubmed-7440737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74407372020-09-02 GFAP at 50 Messing, Albee Brenner, Michael ASN Neuro Article Fifty years have passed since the discovery of glial fibrillary acidic protein (GFAP) by Lawrence Eng and colleagues. Now recognized as a member of the intermediate filament family of proteins, it has become a subject for study in fields as diverse as structural biology, cell biology, gene expression, basic neuroscience, clinical genetics and gene therapy. This review covers each of these areas, presenting an overview of current understanding and controversies regarding GFAP with the goal of stimulating continued study of this fascinating protein. SAGE Publications 2020-08-18 /pmc/articles/PMC7440737/ /pubmed/32811163 http://dx.doi.org/10.1177/1759091420949680 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Article Messing, Albee Brenner, Michael GFAP at 50 |
title | GFAP at 50 |
title_full | GFAP at 50 |
title_fullStr | GFAP at 50 |
title_full_unstemmed | GFAP at 50 |
title_short | GFAP at 50 |
title_sort | gfap at 50 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440737/ https://www.ncbi.nlm.nih.gov/pubmed/32811163 http://dx.doi.org/10.1177/1759091420949680 |
work_keys_str_mv | AT messingalbee gfapat50 AT brennermichael gfapat50 |